OURARING INC.

Lobbying for OURARING INC. · Health technology.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Expenses

$280,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Lobbyists on this filing 1

WALTER KUHN New on this filing

Previously held: Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Taxation/Internal Revenue Code

Issues related to tax benefits for health technology.

Health Issues

Issues related to regulation of health technology. Issues related to insurance coverage of health technology.

Issues related to enforcement of intellectual property rights.

Defense

Issues related to human performance technology; FY26 NDAA and FY26 Appropriations Act.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

OURA HEALTH LTD.

Finland · Oulu · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.